Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 811 AL 825

Exosomes, Endosomes, and Caveolae as Encouraging Targets with Favorable Gut Microbiota for the Innovative Treatment of Alzheimer's Diseases

Nakashima M, Suga N, Fukumoto A, Yoshikawa S, Matsuda S.

Discov Med. 2024 Nov;36(190):2132-2142. doi: 10.24976/Discov.Med.202436190.196.

Molecular and Cellular Foundations of Aging of the Brain: Anti-aging Strategies in Alzheimer's Disease

Dziewa M, Złotek M, Herbet M, Piątkowska-Chmiel I.

Cell Mol Neurobiol. 2024 Nov 28;44(1):80. doi: 10.1007/s10571-024-01514-0.

Monitoring drug Efficacy through Multi-Omics Research initiative in Alzheimer's Disease (MEMORI-AD): A protocol for a multisite exploratory prospective cohort study on the drug response-related clinical, genetic, microbial and metabolomic signatures in Filipino patients with Alzheimer's disease

Climacosa FMM, Anlacan VMM, Gordovez FJA, Reyes JCB, Tabios IKB, Manalo RVM, Cruz JMC, Asis JLB, Razal RB, Abaca MJM, Dacasin AB, Espiritu APN, Gapaz NCLL, Lee Yu MHL.

BMJ Open. 2024 Nov 27;14(11):e078660. doi: 10.1136/bmjopen-2023-078660.

Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease

Zhou F, Zhao Y, Sun Y, Chen W.

J Integr Neurosci. 2024 Oct 30;23(11):197. doi: 10.31083/j.jin2311197.

The role of the FKBP51-Hsp90 complex in Alzheimer's disease: An emerging new drug target

Jeanne X, Török Z, Vigh L, Prodromou C.

Cell Stress Chaperones. 2024 Dec;29(6):792-804. doi: 10.1016/j.cstres.2024.11.006. Epub 2024 Nov 29.

Treatment of Alzheimer Disease

Geldmacher DS.

Continuum (Minneap Minn). 2024 Dec 1;30(6):1823-1844. doi: 10.1212/CON.0000000000001503.

Dysregulation of energy metabolism in Alzheimer's disease

Yuan Y, Zhao G, Zhao Y.

J Neurol. 2024 Dec 2;272(1):2. doi: 10.1007/s00415-024-12800-8.

The Potential Role of Enrichment Environment on Plasticity in Alzheimer's Disease Models: Insights About Therapeutic Approaches

Neves RC, Figueiredo RC, Faria-Melibeu AC.

Curr Alzheimer Res. 2024;21(7):457-469. doi: 10.2174/0115672050348227241128095209.

A preclinical and phase I clinical study of ex vivo-expanded amyloid beta-specific human regulatory T cells in Alzheimer's disease

Yang H, Byun MS, Ha NY, Yang J, Park SY, Park JE, Yi D, Chang YT, Jung WS, Kim JY, Kim J, Lee DY, Bae H.

Biomed Pharmacother. 2024 Dec;181:117721. doi: 10.1016/j.biopha.2024.117721. Epub 2024 Dec 2.

Polyphenols and Their Biogenic Nano-Formulations Targeting BACE1 as Anti-Amyloid Therapies; Meeting the Challenges of Bioavailability, Safety, and Specificity for the Treatment of Alzheimer's Disease

Elawad MA, Ayaz M, Mosa OF, Usman A, Hamdoon AAE, Almawash S, Salim LHM, Ahmed A, Elkhalifa MEM.

Mol Nutr Food Res. 2024 Dec;68(24):e2400525. doi: 10.1002/mnfr.202400525. Epub 2024 Dec 4.

Aging-associated sensory decline and Alzheimer's disease

Hong S, Baek SH, Lai MKP, Arumugam TV, Jo DG.

Mol Neurodegener. 2024 Dec 4;19(1):93. doi: 10.1186/s13024-024-00776-y.

Does Metabolic Manager Show Encouraging Outcomes in Alzheimer's?: Challenges and Opportunity for Protein Tyrosine Phosphatase 1b Inhibitors

Singh R, Jain S, Paliwal V, Verma K, Paliwal S, Sharma S.

Drug Dev Res. 2024 Dec;85(8):e70026. doi: 10.1002/ddr.70026.

Histone Methylation, Energy Metabolism, and Alzheimer's Disease

Fu J, An L.

Aging Dis. 2024 Nov 15;16(5):2831-2858. doi: 10.14336/AD.2024.0899.

The mechanism and related research progress of GLP-1 receptor agonists in treating Alzheimer's disease

Zhu XC, Wang YW, Zhou HW.

Yi Chuan. 2024 Dec;46(12):1017-1027. doi: 10.16288/j.yczz.24-178.

A Recent Update on the Role of Estrogen and Progesterone in Alzheimer's Disease

Suganya S, Ashok BS, Ajith TA.

Cell Biochem Funct. 2024 Dec;42(8):e70025. doi: 10.1002/cbf.70025.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias